Guest: Mike Snyder, PhD, Director, Center for Genomics & Personalized Medicine, Stanford
Listen (6:30) What are the important omics other than genomics?
Listen (6:22) Now studying hundreds of millions of markers to get the complete picture
Listen (3:30) How can a patient benefit from this research?
Listen (1:38) What is the biggest research challenge?
Listen (3:23) Other omics already having an impact on cancer treatment
Genomics is often just the beginning to understanding any disease. There are many other biological mechanisms which are part of understanding disease pathways. Dr. Mike Snyder is perhaps the most biologically tracked man in the world. As part of a research project, he is regularly combing through his own biology, looking at over hundreds of millions of biomarkers on an ongoing basis. This includes his DNA, his proteins, his epigenome, and his microbiome among other ‘omes. Dr. Snyder gives an overview of the various omics which come in to play when understanding the complexity of the human body and disease.
For more info, get the free eBook from Rare Genomics Institute
"Rare Disease Horizons: The Hope of New Research and Technology" is underwritten by the Rare Genomics Institute.